{"id":"sublingual-allergy-immunotherapy-tablet","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Oral itching"},{"rate":"5-10%","effect":"Sore throat"},{"rate":"1-5%","effect":"Swollen tongue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This process, known as desensitization, involves the gradual introduction of increasing amounts of the allergen to the body, allowing the immune system to adapt and reduce its response. Over time, this can lead to a decrease in symptoms such as itching, sneezing, and congestion.","oneSentence":"Sublingual allergy immunotherapy tablets work by exposing the body to small amounts of an allergen to build up tolerance and reduce symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:45.020Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of grass pollen allergy symptoms"}]},"trialDetails":[{"nctId":"NCT05440643","phase":"PHASE1, PHASE2","title":"Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy","status":"ACTIVE_NOT_RECRUITING","sponsor":"ALK-Abelló A/S","startDate":"2022-09-07","conditions":"Peanut Allergy","enrollment":192},{"nctId":"NCT04502966","phase":"PHASE2","title":"Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-11-09","conditions":"Allergic Rhinoconjunctivitis, Grass Pollen Allergy","enrollment":108},{"nctId":"NCT07013123","phase":"PHASE3","title":"Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2025-07-15","conditions":"Severe Asthma, Allergy to House Dust Mites","enrollment":38},{"nctId":"NCT04878354","phase":"PHASE3","title":"A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2021-04-07","conditions":"Allergy","enrollment":952},{"nctId":"NCT04145219","phase":"PHASE3","title":"House Dust Mite Allergy Trial In Children","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2019-10-12","conditions":"Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus, Allergic Rhinitis Due to House Dust Mite","enrollment":1460},{"nctId":"NCT06151938","phase":"","title":"Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis","status":"ENROLLING_BY_INVITATION","sponsor":"ALK-Abelló A/S","startDate":"2023-11-21","conditions":"Allergic Rhinitis Due to House Dust Mite, Allergic Asthma","enrollment":100},{"nctId":"NCT03654976","phase":"PHASE3","title":"Mite Asthma Pediatric Immunotherapy Trial","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2018-02-22","conditions":"Allergic Asthma Due to Dermatophagoides Farinae, Allergic Asthma Due to Dermatophagoides Pteronyssinus, Allergic Rhinitis Due to House Dust Mite","enrollment":533},{"nctId":"NCT05476484","phase":"","title":"Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma","status":"UNKNOWN","sponsor":"ALK-Abelló A/S","startDate":"2022-04-01","conditions":"Allergy, Allergic Rhinitis, Asthma","enrollment":49844},{"nctId":"NCT04541004","phase":"PHASE3","title":"Adolescent Mite Allergy Safety Evaluation","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2020-09-23","conditions":"Allergic Rhinitis, Allergic Rhinoconjunctivitis","enrollment":253},{"nctId":"NCT04176185","phase":"PHASE3","title":"A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber","status":"TERMINATED","sponsor":"ALK-Abelló A/S","startDate":"2019-11-04","conditions":"Allergic Rhinoconjunctivitis","enrollment":80},{"nctId":"NCT05119751","phase":"PHASE4","title":"Vestibular Versus Sublingual Route of AIT Tablets","status":"COMPLETED","sponsor":"Clinique Spécialisée en Allergies de la Capitale","startDate":"2021-10-25","conditions":"Hypersensitivity","enrollment":172},{"nctId":"NCT02005627","phase":"PHASE2","title":"Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2013-09-01","conditions":"Allergic Rhinitis","enrollment":46},{"nctId":"NCT02478398","phase":"PHASE3","title":"Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1025},{"nctId":"NCT02394600","phase":"PHASE4","title":"The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation","status":"COMPLETED","sponsor":"Queen's University","startDate":"2015-04","conditions":"Allergic Rhinoconjunctivitis","enrollment":93},{"nctId":"NCT01469182","phase":"PHASE3","title":"A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2011-11","conditions":"Allergy","enrollment":914},{"nctId":"NCT00978029","phase":"PHASE2","title":"Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2009-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":203},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT00674700","phase":"PHASE2, PHASE3","title":"Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2007-10","conditions":"Allergic Rhinitis","enrollment":509},{"nctId":"NCT02245360","phase":"PHASE3","title":"Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Abbott","startDate":"2014-10","conditions":"Seasonal Allergic Rhinitis","enrollment":107},{"nctId":"NCT00396149","phase":"PHASE1","title":"Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2006-11","conditions":"Birch Pollen-Related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal","enrollment":57},{"nctId":"NCT00901914","phase":"PHASE2","title":"Study of rBet v1 Tablets","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2008-10","conditions":"Birch Pollen-related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal","enrollment":483},{"nctId":"NCT01728285","phase":"PHASE3","title":"Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-03","conditions":"Allergic Rhinitis, Grass Allergy","enrollment":261},{"nctId":"NCT00633919","phase":"PHASE2, PHASE3","title":"Efficacy of SLITone in House Dust Mite Allergic Patients","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2006-07","conditions":"Allergy","enrollment":124},{"nctId":"NCT01224834","phase":"PHASE1","title":"Safety and Tolerability Study of Ragweed SLIT Tablets","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2009-01","conditions":"Rhinitis, Allergic, Seasonal, Ragweed Pollen Allergy","enrollment":60},{"nctId":"NCT00889460","phase":"PHASE1","title":"Safety and Tolerability Study of rBet v1 SLIT Tablets","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2007-11","conditions":"Birch Pollen-Related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal","enrollment":55}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":28,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Acarizax","Odactra"],"phase":"phase_3","status":"active","brandName":"Sublingual allergy immunotherapy tablet","genericName":"Sublingual allergy immunotherapy tablet","companyName":"ALK-Abelló A/S","companyId":"alk-abell-a-s","modality":"Biologic","firstApprovalDate":"","aiSummary":"Sublingual allergy immunotherapy tablets work by exposing the body to small amounts of an allergen to build up tolerance and reduce symptoms. Used for Treatment of grass pollen allergy symptoms.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}